SFTSV NSs protein is a tick antiviral RNAi response suppressor
Authors:
- Mazigh FaresMFMazigh Fares
- Melanie McFarlaneMMMelanie McFarlane
- Rhys H. ParryRhys H. Parry
- Rozeena ArifRARozeena Arif
- Andrew T. ClarkeACAndrew T. Clarke
- Wael KamelWKWael Kamel
- Kelsey DaviesKDKelsey Davies
- Riona Datta-SavageRDRiona Datta-Savage
- Ulrich Schwarz-LinekUSUlrich Schwarz-Linek
- Lesley Bell-SakyiLBLesley Bell-Sakyi
- Marine J. PetitMPMarine J. Petit
- Esther SchnettlerESEsther Schnettler
Open Access
- 12 May 2026
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (20)
Abstract
Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne phenuivirus causing high mortality in humans. While the nonstructural protein NSs is dispensable for replication in interferon-deficient mammalian cells, we demonstrate that NSs is essential for viral replication in tick cells. SFTSV infection triggers canonical Dicer-2-mediated antiviral RNA interference (RNAi) in tick cells, producing virus-derived small interfering RNAs (siRNAs) that target viral transcripts for degradation. We show that NSs functions as a viral suppressor of RNAi by selectively engaging and depleting single-stranded RNAs derived from 22-nucleotide siRNAs, likely limiting their incorporation into RNA-induced silencing complexes (RISC). Complementation with a heterologous RNAi suppressor (p19 protein) partially rescues replication of NSs-deficient virus, validating the RNAi-suppressive function of NSs. These findings reveal that successful tick-borne viral replication requires host-specific immune evasion strategies and establish NSs-mediated RNAi suppression as essential for SFTSV persistence in arthropod vectors.Keywords
Funding Information
- Wellcome Trust (210462/Z/18/Z)
- Medical Research Council (MC_UU_00034/4)
- Medical Research Council (MC_UU_00034/8)
- Medical Research Future Fund (MRF2022950)
- Biotechnology and Biological Sciences Research Council (BB/P024270/1)
- Wellcome Trust (223743/Z/21/Z)
- Horizon 2020 Framework Programme (890970)
- Deutsches Zentrum für Infektionsforschung (TTU 01.708)
- European Research Council (101001634)
- Medical Research Council (MR/R021562/1)
- Medical Research Council (MC_UU_00034/2)
- Medical Research Council (MC_UU_12014/8)
- Medical Research Council (MC_UU_00034/4)
- Medical Research Council (MR/W018608/1)
This publication has 63 references indexed in Scilit:
- Epidemiology, clinical characteristics, and treatment of severe fever with thrombocytopenia syndromeInfectious Medicine, 2022
- Small RNA responses of Culex mosquitoes and cell lines during acute and persistent virus infectionInsect Biochemistry and Molecular Biology, 2019
- Comprehensive Identification of RNA-Binding Domains in Human CellsMolecular Cell, 2016
- RNA interference-mediated antiviral defense in insectsCurrent Opinion in Insect Science, 2015
- Interferons and viruses: an evolutionary arms race of molecular interactionsTrends in Immunology, 2015
- Analysis of Endo-siRNAs in Drosophila2014
- Emerging phlebovirusesCurrent Opinion in Virology, 2014
- Gene silencing in tick cell lines using small interfering or long double-stranded RNAExperimental and Applied Acarology, 2012
- Silencing suppressors: viral weapons for countering host cell defensesProtein & Cell, 2011
- The Drosophila RNA Methyltransferase, DmHen1, Modifies Germline piRNAs and Single-Stranded siRNAs in RISCCurrent Biology, 2007